• News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Celebrities and Cancer
  • Immune Oncology
  • Breast Oncology
  • Gastrointestinal Oncology
  • Lung Oncology
  • Hematology
  • Radiotherapy
  • Cancer Types
  • Science
  • Trial Updates
  • ASCO
  • ESMO
  • ESO
  • MASCC
  • Cancer Center Near Me
  • Oncologist Near Me
  • OncoDaily Party 2025
  • Childhood Cancer
  • Health Policy
  • Hall of Fame
  • OncoIndustry
  • Public Health
  • Oncology Tech
  • Blog Posts
  • BIGR
  • Global Cancer Movement
  • History
  • Oncolibrary
  • OncoThon 2025
  • Yvonne Award 2025
Double Left Left Jun / 2026 Right Double Right
June 2026
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
« May    
OncodailyJournal CancerWorld OncoDaily IO OncoDaily GI Hemostasis Today Fertility News
Linkedin X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
  • Voices
  • Not To Miss
  • FDA Approvals
  • New Paper Alert
  • OncoDaily 100
  • Community
  • OncoDaily Magazine
  • Career Updates
  • Oncology Drugs
  • Dialogues
  • Stories
  • News Feed
  • OncoDaily Pulse
  • OncoGrants
  • OncoDaily TV
  • NewsLetter

OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Elizabeth Mittendorf: Profound Honor to Begin My Term as 2026-27 ASCO President

FDA Approved Durvalumab Plus BCG for BCG-Naïve High-Risk NMIBC

President’s Cancer Panel Meeting Focused on Modifiable Cancer Risk Factors and Prevention Opportunities

Gender Representation in Radiation Oncology in Latin America

Raymond Chan: Big News for Australian Science and Research

Concert for Cures Series Surpasses $28 Million Raised for Cancer Research Following P!NK’s Electrifying Performance at Petco Park

Professor Richard Scolyer Dies at 59, Leaving a Legacy of Courage, Science and Cancer Innovation

High PD-L1 Expression Linked To Shorter PFS With First-Line ALK TKIs In ALK-Rearranged NSCLC

OncoCalendar

16 events found.

Events

Events Search and Views Navigation

Event Views Navigation

  • List
  • Month
Today
  • February 2026

  • Thu 5
    ESMO Preceptorship

    ESMO Preceptorship on Cervical Cancer 2026: Cape Town

    Feb 5 - Feb 6
    Cape Town, South Africa

    The ESMO Preceptorship on Cervical Cancer 2026: Cape Town is a two-day educational course focusing on providing oncologists with a thorough understanding of cervical cancer management, including screening, prevention, diagnosis, […]

  • Thu 5
    Best of ESMO Egypt

    Best of ESMO Egypt 2026

    Feb 5 - Feb 6
    Hilton Cairo Heliopolis El-Orouba, Sheraton Al Matar, El Nozha, Cairo, Egypt

    The Best of ESMO Egypt 2026 is the fourth edition of the premier oncology review conference in Egypt, officially licensed by the European Society for Medical Oncology. Scheduled for February […]

  • Fri 6
    ESMO Summit Africa

    ESMO Summit Africa 2026

    Feb 6 - Feb 8
    Century City Conference Centre 4 Energy Lane, Century City, Cape Town, Western Cape, South Africa

    The ESMO Summit Africa 2026 is a three-day educational event focused on delivering a summary and contextual review of the most significant cancer treatment advances presented at the previous ESMO annual Congress, tailored specifically for the oncology community in Africa. Scheduled to take place in Cape Town, South Africa, from 6 to 8 February 2026, […]

  • Mon 9
    YO4YO Session to Discuss Pregnancy-Associated Cancer Clinical Challenges - BSMO

    Pregnancy-Associated Cancer: Clinical Challenges and Ethical Insights

    Feb 9 • 2:00 PM - 3:00 PM
    Virtual Event

    The ESMO Young Oncologists Committee (YOC) will host the next session of the YO4YO Virtual Session Series on Monday, February 9, 2026, from 14:00 to 15:00 CET. This interactive Clinical Case Discussion, titled "Pregnancy-associated cancer: Clinical challenges and ethical insights," is designed to provide young oncologists with a platform to engage with experts on complex […]

  • Wed 11
    Digital Oncology

    RWD and Digital Oncology: EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026

    Feb 11
    Virtual Event

    The Real World Data and Digital Oncology webinar, EBAI Framework: Evaluating AI-Based Biomarkers in Oncology 2026, is a virtual event that focuses on the practical application of the ESMO Basic […]

  • Thu 12
    Best of ESMO Levant

    1st Best of ESMO Levant

    Feb 12 - Feb 13
    Grand Millennium Hotel Sulaimani Sulaymaniyah, Sulaymaniyah Governorate, Sulaymaniyah, Iraq

    The 1st Best of ESMO Levant is scheduled to take place on February 12–13, 2026, in Sulaymaniyah, Iraq. Organized by the Iraqi Society of Clinical Oncology (ISCO) in collaboration with […]

  • Wed 18
    ESMO Therapeutic Landscapes

    ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026

    Feb 18
    Virtual Event

    ESMO Therapeutic Landscapes: Toxicity of Multispecific Antibodies and Immune-Cell Engagers 2026 is a specialized technical webinar scheduled for February 18, 2026, focused on the safety profiles and clinical management of […]

  • Wed 18
    ESMO Preceptorship

    ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano

    Feb 18 - Feb 19
    Lugano, Switzerland

    The ESMO Preceptorship on Metastatic Bladder and Kidney Cancer 2026: Lugano is a two-day educational course focusing on the management of metastatic bladder and kidney cancer, providing oncologists with a […]

  • Wed 25
    ESMO Guidelines, Real World Cases

    ESMO Guidelines: Real World Cases – Webinar Series: Gastroesophageal Cancer 2026

    Feb 25
    Virtual Event

    The ESMO Guidelines: Real World Cases - Webinar Series: Gastroesophageal Cancer 2026 is a virtual event designed to help medical professionals apply the latest ESMO Clinical Practice Guidelines to the […]

  • March 2026

  • Wed 4
    ESMO Deep Dive

    ESMO Deep Dive: Genitourinary Cancers : Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026

    Mar 4
    Virtual Event

    The ESMO Deep Dive: Genitourinary Cancers: Beyond Cure: Optimizing Medical Care in Metastatic Bladder Cancer 2026 is a specialized scientific webinar designed to provide an in-depth clinical analysis of the treatment landscape for metastatic urothelial carcinoma (mUC). Scheduled for March 4, 2026, this virtual session focuses on the technical challenges of managing advanced disease where […]

  • Wed 4
    Breast Cancer

    ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich

    Mar 4 - Mar 5
    Zurich, Switzerland

    The ESMO Advanced Course on Precision Medicine for Patients with HR+ HER2- Advanced Breast Cancer: Testing, Selecting, Treating 2026: Zurich is a two-day course for experienced oncologists and specialists, focusing on using precision medicine to manage patients with HR-positive, HER2-negative metastatic breast cancer. The event is scheduled to take place on March 4–5, 2026, in […]

  • Fri 6
    ESMO

    ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich

    Mar 6 - Mar 7
    Zurich, Switzerland

    The ESMO Advanced Course on Management of Patients with Localised Bladder Cancer: State-of-the-Art Therapeutic Strategies and Ongoing Research 2026: Zurich is an intensive educational program designed to provide medical oncologists with a comprehensive update on state-of-the-art therapeutic strategies and ongoing research. Scheduled for March 6–7, 2026, in Zurich, Switzerland, the course focuses on multidisciplinary care, […]

  • Wed 11
    ESMO - The Christie Preceptorship

    ESMO – The Christie Preceptorship on Lung Cancer 2026: Manchester

    Mar 11 - Mar 13
    Manchester, United Kingdom

    The ESMO - The Christie Preceptorship on Lung Cancer 2026: Manchester will be held from March 11-13, 2026, in Manchester, United Kingdom. The application deadline is January 21, 2026, at 23:59 CET, and the course is accredited for 16 ESMO-MORA category 1 points. The learning objectives cover the full spectrum of thoracic oncology, from screening […]

  • Thu 12
    ESMO

    The ESMO Sarcoma and Rare Cancers Congress 2026

    Mar 12 • 8:00 AM - Mar 14 • 5:00 PM
    “Palazzo dei Congressi” in Lugano, Switzerland Piazza Indipendenza 4, Lugano, Switzerland

    The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours. The congress will discuss the latest developments in diagnosis, treatment, molecular biology, and classification of sarcomas and other rare cancers. […]

  • Mon 16
    ESMO TAT

    ESMO Targeted Anticancer Therapies Congress 2026

    Mar 16 - Mar 18
    Palais des Congrès de Paris 2 Pl de la Pte Maillot, Paris, Île-de-France, France

    The ESMO Targeted Anticancer Therapies (TAT) Congress 2026 is a major scientific forum organized by the European Society for Medical Oncology (ESMO), focused on accelerating the delivery of life-changing anticancer therapies through early drug development. The congress will be held from March 16 to 18, 2026, at the Palais des Congrès in Paris, France. The […]

  • Thu 19
    The ICHNO 2026

    The ICHNO 2026

    Mar 19 • 8:00 AM - Mar 21 • 5:00 PM
    Fibes - Conference and Exhibition Ave. Alcalde Luis Uruñuela, 1, Seville, Spain

    The ICHNO 2026, the 10th International Congress on Innovative Approaches in Head and Neck Oncology, will be held from 19–21 March 2026 in Seville, Spain, under the theme: “Driven by Biology, Centred on the Person.” This unique event—jointly organized by ESTRO, EHNS, and ESMO—will bring together the full spectrum of multidisciplinary expertise to explore the […]

  • Previous Events
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file
CancerWorld OncoDaily Medical Journal Hemostasis Today OncoDaily IO OncoDaily GI OncoDailyTV

OncoDaily™ | © 2023 - 2025

All rights reserved. Unauthorized reproduction, distribution, or transmission of any content on OncoDaily.com is strictly prohibited. For permission requests or inquiries, please contact OncoDaily directly. By accessing and using OncoDaily.com, you acknowledge and agree to comply with this copyright notice, as well as our Privacy Policy, Editorial Policy, Cookie Policy, and Disclaimer. Continued use of this website constitutes acceptance of all such terms and policies.

Phone number: +1 978 717 48 84

Email: info@oncodaily.com

LinkedIn X Facebook Instagram Youtube Spotify Telegram Bsky Google RSS
About Privacy Policy Editorial Policy Cookie Policy Disclaimer
Crafted by Matemat
Oncology OncoDaily cancer Breast Cancer fight against cancer ASCO Global fight against cancer cancer care Lung cancer Cancer research Headlines ESMO immunotherapy NSCLC MD Anderson Cancer Center cancer treatment cancer awareness colorectal cancer Research clinical trials Childhood Cancer ASCO24 AACR FDA prostate cancer UICC Dana-Farber Cancer Institute American Cancer Society chemotherapy SIOP Pancreatic Cancer European Cancer Organisation Robert Orlowski American Society of Clinical Oncology Myeloma Paper of the Day Paolo Tarantino radiation oncology NCI Vivek Subbiah Myeloma AI National Cancer Institute cervical cancer WHO IASLC healthcare Memorial Sloan Kettering Cancer Center multiple myeloma radiotherapy bladder cancer

European School of Oncology

Sitemap

Hemostasis Today

Fertility News

Oncodaily Journal

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}